Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Academic Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~subject:"Pharmaceuticals"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Cost-effectiveness of long-act...
Similar by person
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Pharmaceuticals
Deutschland
41
Germany
41
Gesundheitskosten
20
Arzneimittel
19
Health care costs
18
Gesetzliche Krankenversicherung
13
Pharmaceutical industry
13
Pharmaindustrie
13
Gesundheitsversorgung
12
Health care
11
Gesundheitswesen
10
Hospital
10
Krankenhaus
10
Public health insurance
10
Arzneimittelmarkt
8
Health care system
8
Patienten
8
Pharmaceutical market
8
Schätzung
8
Wirkungsanalyse
8
Estimation
7
Impact assessment
7
Patients
7
Theorie
7
Arbeitsangebot
6
Beschäftigungseffekt
6
Claims data
6
Costs
6
Disease
6
EU countries
6
EU-Staaten
6
Health policy
6
Krankenversicherung
6
Krankheit
6
Pharmacology
6
Pharmakologie
6
Price regulation
6
Sozialversicherungsbeitrag
6
Theory
6
more ...
less ...
Online availability
All
Free
10
Undetermined
5
Type of publication
All
Article
14
Book / Working Paper
8
Type of publication (narrower categories)
All
Article in journal
11
Aufsatz in Zeitschrift
11
Graue Literatur
3
Non-commercial literature
3
Arbeitspapier
2
Article
2
Working Paper
2
Forschungsbericht
1
more ...
less ...
Language
All
English
21
Undetermined
1
Author
All
Stargardt, Tom
19
Büssgen, Melanie
5
Schreyoegg, Jonas
4
Linder, Roland
3
Blankart, Katharina
2
Jönsson, Bengt
2
Stroka, Magdalena A.
2
Ahrens, Susanne
1
Bauer, Thomas K.
1
Blankart, Carl Rudolf
1
Blankart, Rudolf
1
Busse, Reinhard
1
Drummond, Michael
1
Drummond, Michael F.
1
Gandjour, Afschin
1
Groth, Antje
1
Grünwald, Fabian
1
Koch, Taika
1
Kostev, Karel
1
Lindenbaum, Katharina
1
Mueller, Sabrina
1
Neumann-Böhme, Sebastian
1
Reese, Dallas
1
Roll, Kathrin
1
Rutten, F. F. H.
1
Rutten, Frans
1
Sabat, Iryna
1
Schreyögg, Jonas
1
Talmann, Anna
1
Verheyen, Frank
1
Wilke, Thomas
1
more ...
less ...
Published in...
All
The European journal of health economics : HEPAC ; health economics in prevention and care
5
The European Journal of Health Economics
3
The European journal of health economics
3
Ruhr economic papers
2
Applied economics
1
Das Gesundheitswesen, September
1
HCHE research papers
1
Health care management science
1
Health economics
1
more ...
less ...
Source
All
ECONIS (ZBW)
19
EconStor
2
RePEc
1
Showing
1
-
10
of
22
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Modelling pharmaceutical price changes in Germany : a function of competition and regulation
Stargardt, Tom
- In:
Applied economics
43
(
2011
)
28/30
,
pp. 4515-4526
Persistent link: https://www.econbiz.de/10009388102
Saved in:
2
The impact of reference pricing on switching behaviour and healthcare utilisation : the case of statins in Germany
Stargardt, Tom
- In:
The European journal of health economics : HEPAC ; …
11
(
2010
)
3
,
pp. 267-277
Persistent link: https://www.econbiz.de/10003978858
Saved in:
3
Reimbursement of pharmaceuticals : reference pricing versus health technology assessment
Drummond, Michael F.
;
Jönsson, Bengt
;
Rutten, F. F. H.
; …
- In:
The European journal of health economics : HEPAC ; …
12
(
2011
)
3
,
pp. 263-271
Persistent link: https://www.econbiz.de/10009124305
Saved in:
4
The diffusion of generics after patent expiry in Germany
Blankart, Katharina
;
Stargardt, Tom
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
8
,
pp. 1027-1040
Persistent link: https://www.econbiz.de/10011660160
Saved in:
5
Preferred supplier contracts in post-patent prescription drug markets
Blankart, Rudolf
;
Stargardt, Tom
- In:
Health care management science
20
(
2017
)
3
,
pp. 419-432
Persistent link: https://www.econbiz.de/10011741304
Saved in:
6
The impact of physician-level drug budgets on prescribing behavior
Blankart, Katharina
;
Koch, Taika
;
Kostev, Karel
; …
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
2
,
pp. 213-222
Persistent link: https://www.econbiz.de/10011946212
Saved in:
7
Does health technology assessment compromise access to pharmaceuticals?
Büssgen, Melanie
;
Stargardt, Tom
- In:
The European journal of health economics
24
(
2023
)
3
,
pp. 437-451
Persistent link: https://www.econbiz.de/10014328020
Saved in:
8
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany : a comment
Gandjour, Afschin
- In:
The European journal of health economics
24
(
2023
)
7
,
pp. 1243-1244
Persistent link: https://www.econbiz.de/10014328184
Saved in:
9
Does health technology assessment compromise access to pharmaceuticals?
Büssgen, Melanie
;
Stargardt, Tom
- In:
The European journal of health economics
24
(
2023
)
7
,
pp. 1245-1248
Persistent link: https://www.econbiz.de/10014328187
Saved in:
10
Harmonizing regulatory market approval of products with high safety requirements : evidence from the European pharmaceutical market
Grünwald, Fabian
;
Stargardt, Tom
- In:
Health economics
33
(
2024
)
7
,
pp. 1546-1564
Persistent link: https://www.econbiz.de/10014566060
Saved in:
1
2
3
Next
Last
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
